drugset / Trial / NCT04965116
Progestin-Only Pill Use and Breastfeeding Study
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.
Timeline
- Start
- 2021-10-25
- Primary completion
- 2022-11-04
- Completion
- 2022-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norethindrone | Unknown | 0.35 mg | — |
| Subject | drospirenone | Unknown | 4 mg | — |
Indications
No indication recorded.